1. Home
  2. MYGN vs DIN Comparison

MYGN vs DIN Comparison

Compare MYGN & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.65

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Dine Brands Global Inc.

DIN

Dine Brands Global Inc.

HOLD

Current Price

$28.63

Market Cap

446.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
DIN
Founded
1991
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
446.6M
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
MYGN
DIN
Price
$4.65
$28.63
Analyst Decision
Buy
Hold
Analyst Count
8
6
Target Price
$7.64
$29.67
AVG Volume (30 Days)
1.7M
383.9K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
2.60%
EPS Growth
N/A
N/A
EPS
N/A
1.11
Revenue
$771,400,000.00
$879,300,000.00
Revenue This Year
$7.19
$3.61
Revenue Next Year
$5.64
$0.41
P/E Ratio
N/A
$26.42
Revenue Growth
2.33
8.25
52 Week Low
$3.76
$18.63
52 Week High
$10.25
$39.68

Technical Indicators

Market Signals
Indicator
MYGN
DIN
Relative Strength Index (RSI) 42.83 38.99
Support Level $3.93 $27.52
Resistance Level $5.63 $28.64
Average True Range (ATR) 0.33 1.23
MACD 0.00 -0.02
Stochastic Oscillator 23.53 19.46

Price Performance

Historical Comparison
MYGN
DIN

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

Share on Social Networks: